Catalent makes two key European appointments in oral dose manufacturing

New General Managers announced at Schorndorf and Eberbach sites in Germany

Catalent Pharma Solutions, a global provider of delivery technologies and development solutions for drugs, biologics and consumer health products, has appointed two new General Managers at its plants in Schorndorf and Eberbach in Germany.

Irmgard Neuper is the new General Manager at Schorndorf, which provides large scale, complex oral solid manufacturing with integrated analytical, development, and packaging services.

Neuper joins Catalent from Sandoz, with 17 years of operating and leadership experience in Technical Operations functions in Austria, US, Germany and Brazil. Her most recent role at Sandoz was as Site Head at the company’s Gerlingen, Germany, facility.

Prior to this, she held a number of roles at Sandoz, including Global Quality Project Manager; Site Head for Solid Oral Dosage forms and Liquids in Brazil; Head of Production for Frankfurt Industrial products; and Project Manager for R&D at the Geneva, US, site.

Meanwhile, Luc Burgard has been promoted to General Manager at Eberbach, which is Catalent's softgel manufacturing facility.

Burgard joined Catalent in October 2011 as European Operational Excellence Leader, based in Beinheim, France, before being appointed as Operations Director at the Eberbach site in April 2013.

Prior to joining Catalent, he was employed by Faurecia, a global automotive technology supplier for nine years, working in progressively senior operational roles including as Global Leader in Engineering Methodologies.

You may also like